Entrada Therapeutics (TRDA) Stock Chart & Stock Price History → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free TRDA Stock Alerts $15.47 -0.16 (-1.02%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Entrada Therapeutics Stock Price Performance5 Day Performance+2.25%1 Month Performance+16.75%3 Month Performance+12.67%6 Month Performance+15.45%Year-To-Date Performance+2.52%1 Year Performance+35.23% Receive TRDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. TRDA Stock Chart for Saturday, June, 1, 2024 TRDA Chart by TradingView Entrada Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$15.63$15.47-1.02%$16.08$15.0387,480 shs$522.27 million05/30/2024$15.39$15.63+1.56%$15.86$15.2062,774 shs$527.67 million05/29/2024$16.14$15.39-4.65%$16.45$15.3494,369 shs$519.57 million05/28/2024$15.13$16.14+6.68%$16.24$15.04141,161 shs$544.89 million05/27/2024$15.13$15.13$15.38$15.0433,800 shs$510.79 million05/24/2024$15.02$15.13+0.73%$15.33$15.0433,861 shs$510.79 million Get the Latest News and Ratings for TRDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$16.01$15.02-6.18%$16.05$15.0065,350 shs$507.08 million05/22/2024$15.70$16.01+1.97%$16.27$15.6959,963 shs$540.50 million05/21/2024$15.32$15.70+2.48%$15.72$15.1471,004 shs$530.03 million05/20/2024$14.99$15.32+2.20%$15.41$14.87100,905 shs$517.20 million05/17/2024$14.95$14.99+0.27%$15.34$14.78104,887 shs$506.05 million05/16/2024$14.49$14.95+3.17%$15.01$14.5387,037 shs$504.71 million05/15/2024$14.19$14.49+2.11%$14.81$14.4043,983 shs$489.18 million05/14/2024$14.05$14.19+1.00%$14.83$14.0287,798 shs$479.05 million05/13/2024$14.34$14.05-2.02%$14.84$13.98125,638 shs$474.33 million05/10/2024$14.36$14.34-0.14%$14.46$14.0238,904 shs$482.97 million05/09/2024$14.05$14.36+2.21%$14.44$13.8260,495 shs$483.65 million05/08/2024$13.88$14.05+1.22%$14.25$13.5257,449 shs$473.20 million05/07/2024$13.50$13.88+2.81%$14.11$13.3644,564 shs$467.48 million05/06/2024$13.16$13.50+2.58%$13.83$13.2625,801 shs$454.68 million05/03/2024$13.56$13.16-2.95%$13.84$12.9238,162 shs$443.23 million05/02/2024$13.25$13.56+2.34%$13.59$12.7267,224 shs$456.70 million05/01/2024$11.85$13.25+11.81%$13.35$11.9899,275 shs$445.20 million04/30/2024$12.34$11.85-3.97%$12.39$11.8268,824 shs$398.16 million04/29/2024$12.45$12.34-0.88%$12.55$12.1152,697 shs$414.62 million04/26/2024$12.36$12.45+0.73%$12.73$12.3925,818 shs$418.32 million04/25/2024$12.43$12.36-0.56%$12.58$11.9184,124 shs$415.30 million04/24/2024$12.89$12.43-3.57%$12.79$12.3138,559 shs$417.65 million04/23/2024$13.10$12.89-1.60%$14.03$12.8343,975 shs$433.10 million04/22/2024$12.15$13.10+7.82%$13.13$12.20118,886 shs$440.16 million04/19/2024$11.91$12.15+2.02%$12.19$11.8187,455 shs$408.24 million04/18/2024$12.22$11.91-2.54%$12.40$11.83130,286 shs$400.19 million04/17/2024$12.72$12.22-3.93%$12.89$12.1656,429 shs$410.59 million04/16/2024$12.89$12.72-1.32%$13.01$12.5249,596 shs$427.39 million04/15/2024$12.95$12.89-0.46%$13.54$12.69108,935 shs$433.10 million04/12/2024$13.26$12.95-2.34%$13.51$12.7655,707 shs$435.12 million04/11/2024$12.52$13.26+5.91%$13.29$12.1892,010 shs$445.54 million04/10/2024$13.28$12.52-5.72%$13.32$12.23181,822 shs$420.67 million04/09/2024$13.45$13.28-1.26%$13.66$13.0169,240 shs$446.21 million04/08/2024$13.81$13.45-2.61%$14.13$13.3956,868 shs$451.93 millionWho are Nvidia’s New Silent Partners? (Ad)Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.”04/05/2024$13.83$13.81-0.14%$14.06$13.53104,020 shs$464.02 million04/04/2024$13.81$13.83+0.14%$14.31$13.6852,003 shs$464.70 million04/03/2024$13.88$13.81-0.50%$14.22$13.6255,551 shs$464.02 million04/02/2024$13.76$13.88+0.87%$13.96$13.1764,911 shs$466.37 million04/01/2024$14.17$13.76-2.89%$14.38$13.4170,847 shs$462.34 million03/29/2024$14.17$14.17$14.51$13.67105,311 shs$476.13 million03/28/2024$14.35$14.17-1.25%$14.51$13.67105,311 shs$476.11 million03/27/2024$13.76$14.35+4.29%$14.50$13.6646,082 shs$482.16 million03/26/2024$13.38$13.76+2.84%$14.00$13.2767,944 shs$462.34 million03/25/2024$13.72$13.38-2.48%$13.99$13.1238,641 shs$449.57 million03/22/2024$13.54$13.72+1.33%$13.96$13.3464,728 shs$460.99 million03/21/2024$13.35$13.54+1.42%$13.80$13.1171,898 shs$454.94 million03/20/2024$12.70$13.35+5.12%$13.53$12.3659,837 shs$448.56 million03/19/2024$12.41$12.70+2.34%$12.97$12.2136,200 shs$426.73 million03/18/2024$12.78$12.41-2.90%$12.78$12.3347,845 shs$416.98 million03/15/2024$12.20$12.78+4.75%$12.81$12.09111,858 shs$426.47 million03/14/2024$12.71$12.20-4.01%$12.88$11.8790,555 shs$407.09 million03/13/2024$11.58$12.71+9.76%$12.82$11.35170,506 shs$424.13 million03/12/2024$11.76$11.58-1.53%$11.97$11.4374,657 shs$386.43 million03/11/2024$12.68$11.76-7.26%$12.70$11.6355,466 shs$392.43 million03/08/2024$12.58$12.68+0.79%$12.89$12.3243,125 shs$423.13 million03/07/2024$12.39$12.58+1.53%$12.88$12.2069,769 shs$419.80 million03/06/2024$12.28$12.39+0.90%$12.76$12.02104,101 shs$413.45 million03/05/2024$12.38$12.28-0.81%$13.32$11.92144,569 shs$409.76 million03/04/2024$13.73$12.38-9.83%$13.82$12.10107,735 shs$413.12 million03/01/2024$13.23$13.73+3.78%$13.73$13.13161,348 shs$458.17 million02/29/2024$12.99$13.23+1.85%$13.68$12.8998,097 shs$441.49 million Related Companies: Amneal Pharmaceuticals Stock Price Chart Amphastar Pharmaceuticals Stock Price Chart Vera Therapeutics Stock Price Chart Geron Stock Price Chart Catalyst Pharmaceuticals Stock Price Chart Rocket Pharmaceuticals Stock Price Chart Zai Lab Stock Price Chart Galapagos Stock Price Chart Keros Therapeutics Stock Price Chart Protagonist Therapeutics Stock Price Chart Receive TRDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRDA) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entrada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.